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C3a Activates  the  Respiratory  Burst  in  Human  Polymorphonuclear 
Neutrophilic  Leukocytes Via Pertussis  Toxin-Sensitive  G-Proteins 
By  Jorn Elsner, Martin Oppermann, Wolfgang Czech, and Alexander Kapp 
In contrast to  C5a.  which represents a well-established po- 
tent activator  of  the respiratory burst in polymorphonuclear 
neutrophilic  granulocytes (PMN), the  functional  role  of C3a 
in  the  activation  of  PMN  is,  so far, poorly understood. Herein, 
the  potential  role  of human C3a in the activation  of  the respi- 
ratory  burst  in human PMN  was  investigated.  The release 
of  reactive  oxygen  species (ROS) of PMN from healthy do- 
nors was measured by lucigenin-dependent  chemilumines- 
cence.  C3a  dose-dependently induced the  production  of ROS 
in human PMN in the range between 10 ng/mL and 1,000 
ng/mL, whereas C3a-desArg was inactive. Flow  cytometric 
measurement of HaOp  by dihydrorhodamine-123 labeling of 
anti-CD16-stained PMN showed  that  predominantly  neutro- 
philic PMN are responsible for  the  C3a-induced activation of 
the respiratory  burst.  To exclude that C3a stimulation was 
caused by  contamination with C5a.  the specificity  of  C3a- 
induced activation of PMN  was  shown  using  monoclonal 
antibodies (MoAbs). Accordingly, the effect  of  C3a was  com- 
pletely abolished in the presence of  Fab fragments  of  a 
blocking anti-C3a MoAb. In addition,  blockade of the C5a 
receptor by  the anti-C5a receptor (anti-C5aR) MoAb, S5/1, 
HE  COMPLEMENT  SYSTEM  is  a  major  element of 
the  humoral  defense  reaction.  One  group  of  highly 
active  mediators  that are  generated  by complement activation 
are the anaphylatoxins  C3a,  C4a,  and  C5a.’ These peptides 
play  a  major  role  in  the  pathogenesis of  pulmonary  dys- 
function,  more specifically  of  the adult  respiratory  distress 
syndrome (ARDS).2 Elevated levels  of  C3a are  associated 
with  the  early state  of  ARDS.’ Moreover,  anaphylatoxins 
trigger aggregation  and activation of human  polymorphonu- 
clear neutrophilic leukocytes  (PMN)  in  the  lung resulting in 
a considerable  damage  to  the  lung  paren~hyma.~.~  Further- 
more, there is experimental  evidence that lung injury caused 
by complement activation is related to  damage  of  endothelial 
cells  caused  by  the  generation  of  reactive  oxygen  species 
(ROS) from PMN.’  In the  same  study,  intravenous injection 
of superoxide  dismutase  or  catalase  significantly  protects  the 
pulmonary damage.5 Accumulation of serum  or  tissue C3a 
was  also  found  in  several  other inflammatory diseases  such 
as  chronic  polyathritis,6  inflammatory  arthropathies,’  bullous 
dermatoses  and  In addition,  fluid samples  from 
biopsy specimens taken from perilesional  skin  from patients 
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totally  inhibited  the  C5a-induced  production  of  ROS, 
whereas the C3a response in the presence of the anti-C5aR 
MoAb  was unaffected. The specificity of  the response was 
further confirmed by homologous  desensitization  after  re- 
stimulation with C3a.  In contrast,  no cross-desensitization 
was observed upon  stimulation with C5a. The C3a-induced 
ROS production  by PMN  was  inhibited by pertussis toxin, 
indicating  the  involvement  of  guanine  nucleotide-binding 
proteins (Gi  proteins)  in  the  signal transduction  process initi- 
ated  by  C3a. In addition, stimulation  of  PMN  by  C3a resulted 
in a transient increase in the cytosolic free calcium concen- 
tration ([Ca2’li)  in a dose-dependent manner. In contrast to 
C3a-induced ROS production, C3a did not induce a chemo- 
tactic response in PMN,  indicating  functional  qualitative  dif- 
ferences as compared with C5a. In summary, these  results 
show  that  C3a is a potent activator  of the respiratory burst 
in human PMN. Therefore, these findings  point  to a novel 
role of C3a  in the pathogenesis of inflammatory diseases 
associated with increased C3a levels and PMN  activation. 
0  1994 by The American  Society of Hematology. 
with bullous  dermatoses  and  psoriasis provoked  an  enhanced 
respiratory  burst  of PMN  and eosinophils.’ 
C3a  and  C5a  were shown  to  bind to specific cellular recep- 
tors,  thereby  triggering  specific  cellular  responses.’.“’.’’  Ac- 
cordingly, a  well-known  function of C3a is the induction of 
smooth  muscle contraction,  the release  of  histamine  from 
mast cells  and  the  activation  of guinea-pig  platelets.’  How- 
ever,  in  contrast  to its chemical  analogues  C5dC5a-desArg, 
the  role of  C3a in  the  modulation  of  leukocyte  functions 
is poorly  understood  and controversially  discussed. Earlier 
studies  showed  that  C3a induced  granule release,  chemo- 
taxis, and aggregation  of ne~trophi1s.l~”~  However, most of 
the  effects  reported  earlier  have been hampered  because  of 
the  contamination of C3a preparations  with  C5a.’  More re- 
cent  studies  with  highly  purified  C3a  showed  the existence 
of C3a receptors on  human PMNs,’’,16 interleukin-3-treated 
human  basophils,”  and  tumor-derived  basophils.18 In  addi- 
tion,  it  had been  shown  that  C3a  induces  a  transient  rise 
in  the cytosolic  calcium concentration  ([Ca”],)  in  human 
To evaluate  the potential role of C3a in PMN activation, 
its  effect on  the  respiratory  burst as a  measure  of  the microbi- 
cidal and tissue destructive power  of  PMN  was  determined. 
Moreover, possible  postreceptor  events that are involved  in 
the activation of the respiratory  burst  were investigated. 
PMN.‘~ 
MATERIALS AND  METHODS 
Preparation of  C3a,  C3a-desArg,  and  C5a.  The C3a fragment 
was purified  from human serum that was activated at  37°C  for  I 
hour by  10 mglmL zymosan (Serva, Heidelberg, Germany) in the 
presence of  1 mmol/L DL-2-mercaptomethyl-3-guanidinoethylthio- 
propanoic acid (Calbiochem Novachem, San Diego, CA). After 10% 
polyethylene glycol (PEG 6000; Serva) precipitation at pH 4.0, the 
supernatant was applied to K17R-sepharose at  pH  7.4. K1712  is a 
MoAb with  specificity for C3dC3a-desArg. Highly  purified C3a 
was eluted from the immunoaffinity resin by  0.1 mol/L citrate, pH 
3.5. C3a was finally purified  and concentrated by  cation-exchange 
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chromatography on Mono-S (Pharmacia, Freiburg, Germany) using 
a linear gradient from 0 to 0.5 mol/L  NaCl  in 50 mmol/L phosphate, 
pH 7.0.  The purity of  the C3a preparation was ascertained by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis and silver protein 
staining. The contamination by  C5a was below the detection limit 
of a sensitive enzyme-linked immunosorbent assay,’’ ie, 0.0001%. 
Endotoxin concentration of the C3a preparation was  under the detec- 
tion limits of  the  Limulus amoebocyte lysate assay (Sigma Chemi- 
cals, Deisenhofen, Germany). C3a was converted into the desArg 
form by incubation (1 hour at 37°C)  with porcine carboxypeptidase 
B (Boehringer, Mannheim, Germany) (1O:l  wt:wt). To exclude the 
possibility that carboxypeptidase B has an effect on the  biologic 
activities, FMLP (Sigma) was preincubated with carboxypetidase B 
in  the  same way  as  described for C3a-desArg. Recombinant human 
C5a was purchased from Sigma (Sigma Chemicals) and C5a-desArg 
was prepared as described for C3a-desArg. 
Monoclonal antibodies  (MoAbs)  with specijicity for  C3a and the 
C5a receptor.  The MoAb K13/16 (isotyp IgGlk) recognizes an 
epitope that is present on  human  C3, C3a, and C3a-desArg. This 
MoAb blocks C3a biologic activity in a guinea-pig platelet activation 
assay.”  The anti-C5a receptor MoAb (anti-C5aR MoAb S5/1; iso- 
type IgG2a/k) recognizes an  epitope (Aspl5-Asp21) on the NH2- 
terminal domain of  the C5a receptor.”  This MoAb interferes with 
ligand binding to  its  receptor and  thereby antagonizes C5a/C5a- 
desArg biologic activity.” 
Isolation  of  human  PMN.  Human  granulocytes were isolated 
from heparin-anticoagulated venous blood from normal nonatopic 
healthy donors using Ficoll-Hypaque (Pharmacia) density gradient 
centrifugation as described previously.**  Purified  PMN  (96%  neutro- 
philic PMN; 4% eosinophils) were resuspended in HEPES-buffered 
Hanks’ Balanced Salt Solution (HBSS; GIBCO, Grand Island, NY), 
pH 7.4 containing  1  mg/mL bovine serum albumin (HBSSIBSA). 
Lucigenin-dependent  chemiluminescence (CL).  CL represents a 
sensitive method to  measure the extracellular release of  ROS,23,24 
which is mainly dependent on  the  release of  superoxide anion be- 
cause more than 80% of  the signal is inhibited by  superoxide dismu- 
tase.” Lucigenin-dependent CL was measured using a single-photon 
imaging  system with  a two-dimensional photon counting  system 
(MTP reader; Hamamatsu Photonics, Herrsching, Germany) as de- 
scribed else~here.~~.~~  This system allows to measure and analyze 
kinetic responses of  96 wells simultaneously. In  brief, PMN were 
suspended to a density of  5  X  lo5  cells/mL in HBSSBSA, respec- 
tively, containing 200 pmollL lucigenin (Sigma). Aliquots (100 pL) 
containing 5 X  lo4  PMN were placed into flat-bottom white microti- 
ter plates (Microfluor; Dynatech, Denkendorf, Germany). Measure- 
ments were performed in triplicate at  37°C.  Integral counts from 0 
to  60 minutes incubation interval after addition of  the  stimuli to 
the cell sample were measured and expressed as intensity integral 
counts. 
Hydrogen peroxide  (H20z)  assay.  The intracellular production 
of hydrogen peroxide (H,O,)  was measured with dihydrorhodamine 
123 (DHR; Molecular Probes, Eugene, OR), as described previously 
in  Briefly, the nonfluorescent DHR  is  oxidized by  H202 
during the respiratory burst  to  brightly fluorescent rhodamine 123. 
Human  PMN  (2.5 X  I05/mL) were labeled with 1 pmoW DHR  and 
preincubated for 5 minutes at  37°C. Thereafter, cells were stimulated 
either with  C3a, C5a, or medium  and  incubated for 25 minutes at 
37°C. At  the end  of  this second incubation period, cells were  rou- 
tinely stained with  an  anti-CD16 phycoerythrin (PE)-labeled MoAb 
(3G8-PE, isotype IgGl; Dianova, Hamburg, Germany). Therefore, 
simultaneous measurement of H20z  (emission at 525 nm, green fluo- 
rescence, FL  1) and surface marker expression of  CD16 (emission 
at 585 nm,  red  fluorescence, FL  2) was performed to  distinguish 
between CD  16’  PMN  and CD 16- eosinophils as the source of H20z 
generation. 
Toxin treatment of PMN.  Bordetella pertussis toxin (Calbiochem 
Novabiochem, San Diego, CA) treatment was performed by  incuba- 
tion  of  1  X  10‘  cells/mL for 120 minutes at 37°C  with  and  without 
2 pg/mL pertussis toxin as described el~ewhere.’~  The cells were 
then washed and resuspended in test medium. 
Measurement of [Ca”],  in  human  PMN.  Flow cytometric analy- 
sis was  used to resolve changes in single cell [CaztIi distribution by 
simultaneously staining with  an  anti-CD16 antibody to distinguish 
between CD16’  PMN  and  CD16-  The loading pro- 
cedure of  PMN  with  fluo-3 acetoxymethyl ester (Molecular Probes) 
and  flow  cytometrical analysis was  performed  as  described pre- 
viously.32 The samples were excited by  an  argon laser at 488 nm 
and emission was measured at 530 nm  using  the  logarithmic (log) 
mode  where  an  increase  in  fluorescence reflects  an  increase  in 
[Ca2+]i.3n  Events were continuously acquired using “Chronys”  soft- 
ware (Becton Dickinson) that converted the log fluorescence inten- 
sity means into a linear mean fluorescence channel number.32 
Chemotaxis assay.  Chemotactic activity of  PMN  was  performed 
as described previously using the modified  Boyden  chamber tech- 
nique.33  Briefly,  Boyden chambers (Nuclepore GmbH, Tubingen, 
Germany) were filled  with  different concentrations of  the  stimuli 
and covered with polycarbonate filters (pore size, 3 pm; Nuclepore). 
One hundred microliters of a human  PMN suspension at a concentra- 
tion of  5  X  10S/mL  was added to each chamber. After incubation 
for  1  hour  at  37°C  migrated cells in  the lower part  of  the Boyden 
chambers were lysed by adding 0.1 ’%  Triton X-100, and P-glucuroni- 
dase activity in  the  lysates was determined photometrically using 
p-nitrophenyl P-D-glucuronide as a substrate (all by  Sigma). For 
calculation of  the number of  migrated cells, equivalent to P-gluc- 
uronidase activity determined in  the lower part  of the Boyden cham- 
ber, values were calculated by  a computer-assisted technique from 
a standard curve using known numbers of  unchallenged PMN. Che- 
motactic activity was expressed as chemotactic index: quotient of 
the number of migrating cells in presence of stimuluslmigrating cells 
in presence of medium. 
Statistical analysis.  Unless otherwise stated, the data in the  text 
and  figures  were expressed as mean t  SEM. Analysis of  variance 
(ANOVA) was used for comparing experimental group to control 
value. If  global test for differences was significant at  the  5% level, 
pair  wise  tests for differences between groups were applied (Stu- 
dent’s t-test for paired data using 5% significance level, closed test 
procedure). 
RESULTS 
C3a, but  not  C3a-desArg, induces  the  respiratory  burst 
in PMN.  The effect  of  highly  purified C3a on the activation 
of  the respiratory  burst  in  human  PMN  was  investigated 
using  lucigenin-dependent  CL.  As  shown  in Figs 1 and 2, 
C3a significantly  induced  a  dose-dependent  production  of 
ROS in  human  PMN  in the  range  of  10 and 1000 ng/mL. 
Half-maximal  and  maximal  reactive oxygen  production  were 
found at S0 ng/mL and 1000 ng/mL  C3a,  respectively  (Fig 
2). The  response  upon  stimulation  with  C3a  was  rapid,  reach- 
ing  maximum  values  within 2 minutes  at  37°C (Fig  l), and 
was similar to  the  reaction  of cells which  were  exposed  to 
C5a.  As  compared  with  C3a,  C5a  was  more  active  (Fig  2). 
In contrast  to  C3a,  C3a-desArg  (100 to  1,000 ng/mL)  did 
not activate  the respiratory  burst  in PMN (Fig 2). However, 
although the  response  was not  as  pronounced as  the  signal 
obtained  with  CSa  (Fig 2), CSa-desArg  significantly  induced 
the production  of ROS (100 to 1,000 ng/mL) in PMN (Fig 
2). To exclude  the  possibility  that  carboxypeptidase B  by 
itself  has  an  effect  on  the  biologic  activities,  FMLP  was 3326  ELSNER  ET AL 
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preincubated with carboxypetidase B. This combination did 
not  affect  the  FMLP-induced  ROS  production  (data  not 
shown) suggesting that the abrogated effect of  C3a-desArg 
was not caused by  an  unspecific inhibition of carboxypepti- 
dase B. 
Flow cytometry shows that C3a activates the respiratoq 
burst  in  CD16'  PMN.  To rule out the possibility that  the 
C3a-induced activation of  the respiratory burst  in  neutro- 
Fig  1.  C3a  induces  the  re- 
lease  of  ROS  in human  PMN. 
Time  course  of  C3a-induced  pro- 
duction of  ROS by PMN using 
lucigenin-dependent  CL.  One 
representative  experiment  of 
five is  shown. 
philic  granulocytes is  caused by  contaminating other  cell 
types,  particularly  eosinophils,  H202 was  measured  in 
CD16'  cells  using  flow  cytometry.  Stimulation  of  anti- 
CD16-stained  cells with C3a resulted in a significant fluo- 
rescence increase indicating the production of  H202  (Figs 3 
and 4). However, C5a was  much  more  active (Fig 3). Dot- 
plot analysis of  anti-CD16-stained  cells showed  that  pre- 
dominantly CD16'  cells  (97% 5 3%;  mean  t  SD). ie, 
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Fig 2.  Dose-dependent  effect  of C3a on the respiratory burst in human PMN. Cells were stimulated with different concentrations  of  C3a. 
Cia-desArg, C5a.  or  C5a-desArg.  Data  are  expressed  as the mean  of integral intensity counts ? SEM of  PMN from five different experiments 
using lucigenin-dependent CL.  Global  differences  between groups: P S  .001 (ANOVAI;  *P 5  .01, **P S .OOl,  compared with  the medium 
control (Student's t-test). C3a  ACTIVATES  THE  RESPIRATORY  BURST  IN PMN 
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DHR (H202) 
Fluorescence 1 
Fig  3.  Effect of C3a on  H202  production  by  CD16'  PMN. Flow  cyto- 
metric analyses of HZOZ  production in DHR-labeled PMN stimulated 
either with C3a  (500 ng/mL),  C5a  (l00 nglmL)  or  medium.  Upper 
graph:  Multiple  histogram  analyses of  CD16'  gated PMN.  Lower 
graphs:  Dot-plot analyses of  simultaneous  measurement  of  H202 
(DHR,  Fluorescence 1) and surface marker  expression of CD16-PE 
(Fluorescence  2) in PMN. The data are representative for  at  least four 
experiments. 
neutrophilic PMN, were responsible for the fluorescence in- 
crease induced by  C3a or CSa, respectively (Fig 3). How- 
ever,  the  smaller CD16-  cell  population,  ie,  eosinophils, 
were also activated by  C3a and  CSa,  respectively. 
Specificio of  C3a-induced activation of  the  respiraton 
burst.  To rule out the possibility that the effects of  C3a 
are caused by  contamination by  CSa, the specificity of  the 
C3a-induced activation of the respiratory burst was investi- 
gated  using  MoAbs with  specificity  for the  CSa  receptor or 
3321 
C3a. Preincubation of  PMN  with  11 &mL  of  the  anti-CSa 
receptor MoAb, SS/I  (anti-CSaR). which  blocks  a binding 
site of the CSa  receptor."  totally  abolished the  CSa-induced 
production of  ROS  (Fig S). In contrast, the  C3a-induced 
production  of  ROS  of  anti-CSaR MoAb-treated PMN  was 
unaffected (Fig S).  Furthermore, preincubation of C3a with 
a threefold  molar excess of  Fab  fragments of  a MoAb (anti- 
C3a), which neutralizes C3a activity in a guinea-pig platelet 
adenosine triphosphate (ATP)-release assay.20 totally abol- 
ished the C3a-induced production of  ROS  in PMN  (Fig S). 
In contrast. anti-C3a MoAb  did  not  diminish the  production 
of  ROS  when  PMN  were  stimulated with  CSa  (data not 
shown). 
C3a-ind~rced  ccctivation of  the respirrrton hrst  undergoes 
homologolrs desensitization. but not cross-de.serlsiti,atir,n to 
C5a.  To further examine the  specificity  of  the anaphylat- 
oxin-induced  activation  of  PMN,  desensitization  experi- 
ments were performed  using  C3a  and  CSa  as the agonists. 
To this end  PMN  were  prestimulated with  C3a.  CSa.  or 
medium, respectively (Fig 6A). After  1 hour  the  cells were 
restimulated with  the same agents. Whereas C3a-prestimu- 
lated cells were not activated by  restimulation with  C3a.  CSa 
was able to  induce the  production  of  ROS  in these cells 
(Fig  6B). In  addition. CSa-prestimulated PMN  showed  a 
production  of  ROS  only  after restimulation with  C3a. but 
not  with  CSa  (Fig 6B). Stimulation of  PMN  by  phorbol 
myristate acetate (PMA). a receptor-independent agonist. as 
a third  stimulus resulted  in an  additional  ROS  production 
(data not  shown). Therefore. desensitization of  C3a or CSa 
was not caused by  a lack of  recovery of the cells to  produce 
additional ROS. 
C3a-induced actisation of the respiraton burst  is pertus- 
sis toxin sensitive.  To get  more  insight into the postreceptor 
events after C3a stimulation, possible inhibitory effects of 
pertussis toxin  were  investigated using lucigenin-dependent 
chemiluminescence.  Pretreatment of  PMN  with  pertussis 
Medium  C3a  C5a  PMA 
Fig 4.  C3a  induces the  production  of  H202 in human PMN.  H202 
production  of  PMN after stimulation  with  medium, C3a (500 nglmL), 
C5a (100 ng/mL) and PMA (10 ng/mL). Data are shown as mean log 
fluorescence channel number  t  SEM;  global differences between 
groups: P c  .001 (ANOVA); *P  c  .001 compared with medium  stimu- 
lated cells (Student's t-test). 3328 
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Fig 5.  Effect  of different MoAbs on C3a-induced respiratory burst. 
(1) Effect of anti-C3a MoAb: C3a was preincubated with a threefold 
molar excess  of  Fab fragments of  a MoAb against C3a  (anti-C3al 
before stimulation as  described in Materials and Methods. (2) Effect 
of  anti-C5aR  MoAb  PMN  were preincubated for 30 minutes in  the 
presence  of 11 pg/mL of the anti-C5a receptor (anti-CLaR)  MoAb S5/ 
1,  and were  then  stimulated with C3a  and C5a.  respectively. Data 
represent the mean of integral intensity counts f  SEM of PMN  from 
five different experiments using lucigenin-dependent CL. *P  c .001 
compared with C3a alone, **P  c ,001 compared with C5a alone IStu- 
dent's t-test). 
toxin,  which  adenosine  diphosphate  (ADP)-ribolysates  Gi 
 protein^,'^ inhibited  the  C3a-induced  production of ROS  (Ta- 
ble  l).  The  C5a-induced  ROS  production  was  also  totally 
inhibited  in the  presence  of  pertussis  toxin  (Table  l). In 
contrast  to  C3a  and  C5a,  the  PMA-induced  activation of the 
respiratory  burst  after  pertussis  toxin  treatment  was  only 
slightly  reduced  (Table 1). 
Changes of [Ca"],  in PMN in response to C3a.  Besides 
the  involvement of Gi  proteins  in the  C3a-mediated activa- 
tion of the respiratory burst,  changes  in [Ca2'],  play an im- 
portant role  as  a second messenger.34 Therefore, flow cyto- 
metric  analysis  was  used  to  resolve  changes  in  single  cell 
[Ca2+Ii  distribution  by simultaneously  staining  with  an  anti- 
CD16 antibody  to  distinguish  between  CD16'  PMN  and 
CD16-   eosinophil^.^'  C3a  induced  a  rapid  dose-dependent 
increase  in  [Ca"],  in  PMN  reaching  maximum  levels  10 
seconds after  stimulation  (Fig  7).  C3a  led to increases  of 
arbitrary  fluorescence  units  from  236 ? 10 (medium)  to  432 
? 20  (C3a  1000 ng/mL; P 5  .001 v medium)  and  350  t 
25  (C3a  100  ng/mL; P  5  ,001  v medium).  This  [Ca2'Ii 
increase  was transient  and decreased  within  60 seconds  to 
basal  levels  of  unstimulated  cells  (Fig  7).  Whereas  C3a- 
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induced  [Caz'Ii  increase  in  PMN returned to  the basal level 
within 60  seconds,  the C5a-induced  [Ca*'],  increase (maxi- 
mum  436  t  30 arbitrary  fluorescence  units;  P s ,001  v 
medium)  was  still  elevated  (Fig  7, below)  and  returned  to 
the  basal  level within  160  seconds  (data  not  shown). 
C3a  does  not  induce  chemotaxis  of  PMN.  Because 
[Ca"],  transients  and G-proteins  are  also  involved  in  the 
signal transduction of PMN  chemotaxi~,~~  the modified Boy- 
den  chamber  technique  was  performed  to  investigate  the 
chemotactic activity  of C3a.  C3a  did  not  induce  a  significant 
chemotactic  response in human  PMN  in the  range  between 
1  and 1,000  ng/mL  (chemotactic  index: 1.08 t  0.1). In con- 
trast, C5a  dose-dependently  (at  1  ng/mL:  4.2  ? 0.4; at  10 
ng/mL:  4.4  2  0.5;  at  100 ng/mL:  2.7  2 0.2)  induced  a 
chemotactic  response in PMN. 
DISCUSSION 
Increased  serum levels  of  C3a  are  suggested  to reflect 
complement activation  in  a  variety  of inflammatory  diseases, 
particularly  in  ARDS.2-5  Recently,  it  was  shown  that  lung 
damage  was  dependent on complement activation  as  well  as 
the  generation  of ROS by PMN.5 However, the  pathophysio- 
logic role of C3a in the activation of effector cells,  such  as 
PMN,  during inflammation could not be determined.'  To get 
more insight  in the potential role of human  C3a  in  inflamma- 
tion, its effect  on  the  release of ROS by PMN  was  investi- 
gated. 
C3a significantly induced  the  production  of ROS in  human 
PMN in  a  concentration-dependent  manner, whereas  C3a- 
desArg  was  inactive. Under physiologic  conditions the  car- 
boxypeptidase-N rapidly removes the C-terminal arginine of 
C5a  and  C3a  that  is  essential  for most  of  their  biologic 
activities.3s The inability  of C3a-desArg  to  stimulate  PMN 
is in accordance with  previous  findings  that  removal  of the 
arginine  residue  leads  to  a complete abrogation  of C3a bind- 
ing's and  biologic  activity."  The  C5a-desArg-induced  acti- 
vation of the respiratory  burst  in  PMN  is  also in accordance 
with reports on the biologic  activity of C5a-desArg, although 
CSa-desArg  is a  weaker  stimulus than  C5a.'4.36  However, 
our results are in  contrast to previous studies that C3a is  not 
able  to  stimulate  effector  functions  of  PMN.','',l7  A  possible 
explanation of these conflicting  results  might be  the  compar- 
atively higher sensitivity of  detection of ROS by lucigenin- 
dependent  chemiluminescence  than by superoxide-dismutase 
inhibitable  reduction  of cytochrome C  that  had been shown 
in  several  st~dies.~*.~~  On the  other  hand,  it  is  tempting  to 
speculate that  C3a-mediated  activation  of  the  respiratory 
burst  is only possible if  serum  carboxypeptidase-N  is com- 
pletely  blocked  during  the  preparation of C3a. 
To  rule  out  that  C3a-induced  ROS production  is  caused 
by contaminating  eosinophils  in the  cell preparations, simul- 
taneous  measurement  of  H202  and antibody  staining  was 
performed  using  flow cytometry. This approach showed that 
C3a-induced  production of H202  by CD16-positive  PMN is 
not caused by contaminating  eosinophils,  although  the  latter 
are  also  able  to produce ROS in response to  C3a  and 
Thus, the  activation  of  the  respiratory  burst  in response  to 
C3a could  be  confirmed  by  using  an  additional  sensitive 
method. C3a  ACTIVATES  THE  RESPIRATORY  BURST  IN PMN 
A 
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Fig 6.  C3a undergoes homologous desensitization, but  not  cross-desensitization to C5a.  ROS production was assessed by lucigenin- 
dependent CL as described in Materials and Methods. Cells were first stimulated with C3a.  C5a.  or  medium for 1 hour at 37°C (A). Thoreafter, 
PMN  were restimulated with  the  same stimuli as indicated (B). One representative desensitization experiment of  four  is  shown. Note  the 
difference in scale between first stimulation and restimulation. 
The specificity of the C3a-induced activation of  the respi- 
ratory burst was investigated using MoAbs against the anti- 
C5aR and C3a (anti-C3a). Blockade of specific functionally 
important surface receptors by MoAbs often lead to a loss 
or abolition of the stimulus-induced cell response. Recently, 
anti-C5aR antibodies were found to effectively block C5a- 
mediated PMN enzyme release and [Ca2+Ii  transients."  In 
the present study, it  was  shown that the anti-CSaR MoAb 
S5/1 blocked the production of  ROS upon stimulation with 
C5a, but  not  with C3a, thereby providing evidence that the 
anti-C5aR MoAb recognizes a functionally important epi- 
tope of  the C5a receptor on PMN. Therefore, the C3a-in- 
duced  production  of  ROS  in  the  presence  of  anti-C5aR 
MoAb could not be explained by a contamination of purified 
C3a with traces of  C5a. Furthermore, the C3a-induced pro- 
duction of ROS could be antagonized by Fab fragments of 
a C3a-specific MoAb that had been shown to neutralize C3a 
activity in a guinea-pig platelet ATP-release assay." 
Homologous desensitization of C3a, but failure to cross- 
desensitize upon stimulation with C5a further confirmed the 
Table 1.  C3a-Induced  ROS  Production by PMN is 
Inhibited by  Pertussis Toxin 
Pertussis 
Toxin (2 wg1 
Stimuli  mL)  Medium 
Medium  8.4 2 1.3  12.8  5 3.9 
C3a (500 ng/mL)  8.7  -c  3.1  180.3  t- 72.5 
C5a (l00  ng/mL)  8.5  2 1.7  202.9 ? 53.5 
PMA (1 ng/mL)  335.4  5 8.9  468.7  t- 90.4 
Cells were preincubated with pertussis toxin or medium  for  2  hours 
as described in Materials and Methods. Thereafter, PMN were stimu- 
lated either with medium, C3a,  C5a,  or PMA.  Data  are  expressed as 
the mean of integral  intensity  counts (XlO-')  -c  SEM using lucigenin- 
specificity of  C3a-induced PMN activation. These data are 
also in accord with previous reports showing homologous 
desensitization of  C3a-induced [Ca2+Ii  changes in  human 
PMNL6  and in tumor-derived basophils."  Although cross- 
desensitization experiments are only a preliminary and indi- 
rect way  of  showing the specificity of novel ligand-receptor 
interactions, previous  studies in  leukocytes with  C3dC5a 
have shown the predictive value of  this experimental ap- 
proach." 
Stimulation of  PMN  by  chemoattractants such as C5a in- 
volves pertussis-toxin-sensitive  Gi proteins followed by an 
activation of  phospholipase C.38  The latter enzyme cleaves 
phosphatidylinositol 4,5-bisphosphate into the intracellular 
messengers inositol 1,4,5-trisphosphate (IP,)  and 1,2-sn-di- 
acylglycerol (DAG)."  Soluble IP3 causes the release of se- 
questered Ca2'  into the cytosol, which in combination with 
DAG, results in the activation of protein kinase C."  Protein 
kinase C has been implicated in  many biologic regulatory 
mechanisms, including the activation of  the  NADPH  oxi- 
dase.34,3x  Herein, we could show  that  pertussis toxin, which 
ADP-ribosylates Gi proteins, inhibited the C3a-induced pro- 
duction of  ROS. Therefore, C3a-induced activation of  the 
respiratory burst in  PMN  is mediated via pertussis-toxin- 
sensitive Gi proteins. These data are in agreement with  pre- 
vious  findings that  C3a  stimulates [Ca2+Ii  transients in  a 
pertussis-toxin-sensitive  manner in PMN.I6 
The role of  C3a-induced [Ca"],  changes in PMN is dis- 
cussed c~ntroversially.'~~'~  In contrast to Bischoff et all7  who 
reported that C3a is not able to induce [Ca"],  transients in 
PMN, Klos et all6  clearly showed  that  C3a induces a transient 
rise in [Ca2+Ii.  Besides these controversial results and evi- 
dence that [Ca2'],  transients are involved in the activation 
of the respiratory b~rst,~~.~'  flow cytometric measurement of 
single cell  [Ca"],  in this study showed that C3a was also 
dependent CL.  able to induce transient [Ca2+Ii  changes in CD16+ PMN. The 3330  ELSNER  ET AL 
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Fig 7.  C3a  induces a transient increase in [Ca2'li in a dose-depen- 
dent manner. Flow cytometric analyses of fluo-3-loaded PMN. Data 
in (A) indicate the  time  course  of  ICa2'li  changes  upon  stimulation 
with different doses  of  C3a.  Data in (B) compare the time course  of 
ICa2'l,  changes  induced  by  C3a  and  C5a.  One  representative  experi- 
ment of  four  is  shown where the mean channel  fluorescence  ([Cat'],) 
is plotted against the  time as  described  in  Materials and Methods. 
Arrows indicate  the  time  of addition of the stimuli or medium, respec- 
tively. 
smaller and shorter [Ca"],  signal in PMN after stimulation 
with a maximal dose of  C3a, compared with  that induced by 
a maximal dose of C5a, is consistent with findings described 
previously.'6 Therefore, besides the involvement of  Gi  pro- 
teins, [Ca2'Ii transients are also involved in the signal trans- 
duction process upon stimulation with C3a. 
Because  [Ca"Ii  transients and  Gi  proteins are also in- 
volved in the signal transduction of PMN chemotaxi~,~~  the 
effect of C3a on the chemotactic activity of PMN  was inves- 
tigated. In contrast to C5a, C3a did not induce a chemotactic 
response of human PMN. These data are in agreement with 
previous studies showing that C3a does not stimulate chemo- 
taxis in PMN.' Moreover, these data clearly show that PMN 
activation upon  stimulation with  C5a and C3a differed in 
the quality of  the cell response. 
In summary, this study showed biologic effects of  C3a in 
the activation of human  PMN. C3a-induced activation of the 
respiratory burst was shown to be dependent on binding to 
specific  C3a receptors, which are different from C5a recep- 
tors. Stimulation of  PMN by  C3a stimulation involved per- 
tussis toxin-sensitive Gi proteins and  led  to a transient rise 
in the [Ca2+],  . In contrast to C5a, C3a did not induce chemo- 
taxis in  PMN.  Therefore, these  findings point  to  a novel 
role  of  C3a in  the pathogenesis of  inflammatory diseases 
associated with increased C3a levels and  PMN  activation, 
particularly in ARDS. 
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